The surface shows that prior-authorization failure is often a routing and evidence-packaging defect, not a purely clinical one.
Payer rules become operational only when owners, evidence targets, and denial blockers are mapped into the same lane.
Approval posture makes reimbursement and care-delay risk visible before a case drops into a denial or appeal spiral.